SCHEMBL12499486

SCHEMBL12499486

COc1cc2c(Oc3ccc(N=O)cc3)ccnc2cc1O

nearest known ligand 0.60

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FGFR2 P21802 7/20 0.56
PDGFRA P16234 7/20 0.55
PDGFRB P09619 1/20 0.55
KDR P35968 5/20 0.54
MET P08581 1/20 0.51
KIT P10721 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10453000 0.85 FGFR2 (0.52) FGFR2PDGFRAPDGFRBKDRMET
SCHEMBL17489704 0.85 PDGFRA (0.65) FGFR2PDGFRAPDGFRBKDR
SCHEMBL4141203 0.84 FGFR2 (0.60) FGFR2PDGFRAPDGFRBKDR
SCHEMBL12500026 0.82 MET (0.52) FGFR2PDGFRAPDGFRBKDRMET
SCHEMBL4141201 0.82 FGFR2 (0.59) FGFR2PDGFRAPDGFRBKDRMET
SCHEMBL10296329 0.81 PDGFRB (0.55) FGFR2PDGFRAPDGFRB
SCHEMBL1893582 0.81 PDGFRA (0.70) FGFR2PDGFRAPDGFRBKDRMET
SCHEMBL13955463 0.80 PDGFRA (0.49) FGFR2PDGFRAPDGFRBKDRMET
SCHEMBL12500763 0.80 MET (0.57) FGFR2PDGFRAPDGFRBKDRMET
SCHEMBL12501921 0.80 AXL (0.62) FGFR2PDGFRAPDGFRBKDRMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973160-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-07-05 US disclosed
US-20110118470-A1 NITROGEN-CONTAINING AROMATIC DERIVATIVES FUNAHASHI YASUHIRO 2011-05-19 US disclosed
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives GNG2, GCG, FRG1 FGFR2 969/4885PDGFRA 3131/4885PDGFRB 3824/4885
US-20110118470-A1 NITROGEN-CONTAINING AROMATIC DERIVATIVES GNG2, GCG, FRG1 FGFR2 1118/4885PDGFRA 3135/4885PDGFRB 3850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.